The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.
ANDREW POLLACK, NY Times: Technology
Thu, 07/02/2015 - 10:56am
The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.